Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Daiichi Sankyo
Teva
Julphar
Covington
Healthtrust
Farmers Insurance
Dow
AstraZeneca

Generated: July 17, 2018

DrugPatentWatch Database Preview

Trospium chloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for trospium chloride and what is the scope of trospium chloride freedom to operate?

Trospium chloride
is the generic ingredient in three branded drugs marketed by Allergan, Actavis Labs Fl Inc, Paddock Llc, Upsher-smith Labs, Apotex, Glenmark Generics, Heritage Pharms Inc, and Invagen Pharms, and is included in ten NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Trospium chloride has fifteen patent family members in eleven countries.

There are sixteen drug master file entries for trospium chloride. Eleven suppliers are listed for this compound.
Pharmacology for trospium chloride
Synonyms for trospium chloride
(1alpha,5alpha)-3beta-[(Hydroxydiphenylacetyl)oxy]spiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]
[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate chloride
[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate;chloride
[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-oxidanyl-2,2-diphenyl-ethanoate chloride
1001323-19-8
10405-02-4
1E6682427E
2-hydroxy-2,2-diphenylacetic acid [(1S,5R)-3-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]yl] ester chloride
3-((hydroxydiphenylacetyl)oxy)-spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium chloride
3alpha-Hydroxyspiro(1alphah,5alphah-nortropane-8,1'-pyrrolidinium) benzilate
3alpha-Hydroxyspiro(1alphaH,5alphaH-nortropane-8,1'-pyrrolidinium) chloride benzilate
405T024
47608-32-2
8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride
A800884
AB0000782
AB01274814_02
AB01274814-01
AB2000646
AC-4235
AC1NR4ST
AKOS015833209
AM84314
API0004533
AS Xvii
Azoniaspiro Compound XVII
Azoniaspiro(3-alpha-benziloyloxy-nortropan-8,1'-pyrrolidine)-chloride
B-1868
BC209629
BCP0726000291
CAS-10405-02-4
CHEBI:32270
CHEMBL1888176
CHEMBL3084748
Chlorure de trospium
Chlorure de trospium [INN-French]
Cloruro de trospio
Cloruro de trospio [INN-Spanish]
CS-2572
DB00209
DSSTox_CID_3724
DSSTox_GSID_23724
DSSTox_RID_77166
DTXSID6048337
DTXSID7023724
EINECS 233-875-4
FT-0636699
HMS3656C16
HY-B0461
IP631
Keptan
MFCD00865254
MolPort-005-935-494
MolPort-046-033-481
NCGC00167438-01
NCGC00167438-02
Relaspium
RVCSYOQWLPPAOA-QKYUOBHYSA-M
s2549
Sanctura
Sanctura XR
Santura
SCHEMBL119810
SCHEMBL13836646
SCHEMBL2447242
SCHEMBL25785
Spasmex
Spasmo 3
Spasmo-lyt
Spiro (8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium), 3-((hydroxydiphenylacetyl)oxy)-, chloride, (1alpha, 3beta, 5alpha)
Spiro(1-alpha-H,5-alpha-H-nortropane-8,1'-pyrrolidinium), 3-alpha-hydroxy-, chloride, benzilate
Spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium, 3-((hydroxydiphenylacetyl)oxy)-, chloride, (1alpha,3beta,5alpha)-
Spiro[8azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5);Spiro[8azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5)
ST24050330
T4Y8ORK057
Tox21_112442
Tox21_112442_1
Trospii chloridum
Trospii chloridum [INN-Latin]
Trospium
Trospium (chloride)
Trospium cation
Trospium chloride (Sanctura)
Trospium chloride [USAN:USP:INN:BAN:JAN]
Trospium Cl
Trospiumchlorid
UNII-1E6682427E
UNII-T4Y8ORK057
Uraplex
W-108827
ZINC100016084
ZINC100371992
ZINC12503068

US Patents and Regulatory Information for trospium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glenmark Generics TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091575-001 Aug 13, 2010 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Paddock Llc TROSPIUM CHLORIDE trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 201291-001 May 24, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
Medtronic
Queensland Health
Accenture
Mallinckrodt
Boehringer Ingelheim
Express Scripts
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.